These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 25514767)

  • 1. PI3K signalling in inflammation.
    Hawkins PT; Stephens LR
    Biochim Biophys Acta; 2015 Jun; 1851(6):882-97. PubMed ID: 25514767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of class I, II and III PI 3-kinases in platelet production and activation and their implication in thrombosis.
    Valet C; Severin S; Chicanne G; Laurent PA; Gaits-Iacovoni F; Gratacap MP; Payrastre B
    Adv Biol Regul; 2016 May; 61():33-41. PubMed ID: 26714793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signalling through Class I PI3Ks in mammalian cells.
    Hawkins PT; Anderson KE; Davidson K; Stephens LR
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):647-62. PubMed ID: 17052169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacological model reveals biased dependency on PI3K isoforms for tumor cell growth.
    Wang X; Li JP; Yang Y; Ding J; Meng LH
    Acta Pharmacol Sin; 2013 Sep; 34(9):1201-7. PubMed ID: 23892273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoform selective phosphoinositide 3-kinase gamma and delta inhibitors and their therapeutic potential.
    Ghigo A; Hirsch E
    Recent Pat Inflamm Allergy Drug Discov; 2008 Jan; 2(1):1-10. PubMed ID: 19075988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel roles for class II Phosphoinositide 3-Kinase C2β in signalling pathways involved in prostate cancer cell invasion.
    Mavrommati I; Cisse O; Falasca M; Maffucci T
    Sci Rep; 2016 Mar; 6():23277. PubMed ID: 26983806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Isoform Selective Roles of PI3Ks in Dendritic Cell Biology and Function.
    Aksoy E; Saveanu L; Manoury B
    Front Immunol; 2018; 9():2574. PubMed ID: 30498491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of PI3Kdelta and PI3Kgamma in inflammatory arthritis and tissue localization of neutrophils.
    Randis TM; Puri KD; Zhou H; Diacovo TG
    Eur J Immunol; 2008 May; 38(5):1215-24. PubMed ID: 18412166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3K isoforms in cell signalling and vesicle trafficking.
    Bilanges B; Posor Y; Vanhaesebroeck B
    Nat Rev Mol Cell Biol; 2019 Sep; 20(9):515-534. PubMed ID: 31110302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI3K class IB pathway.
    Andrews S; Stephens LR; Hawkins PT
    Sci STKE; 2007 Oct; 2007(407):cm2. PubMed ID: 17925573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI3Kgamma is the dominant isoform involved in migratory responses of human T lymphocytes: effects of ex vivo maintenance and limitations of non-viral delivery of siRNA.
    Smith LD; Hickman ES; Parry RV; Westwick J; Ward SG
    Cell Signal; 2007 Dec; 19(12):2528-39. PubMed ID: 17900864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterisation of tetracycline-regulated phosphoinositide 3-kinase mutants: assessing the role of multiple phosphoinositide 3-kinases in chemokine signaling.
    Curnock AP; Ward SG
    J Immunol Methods; 2003 Feb; 273(1-2):29-41. PubMed ID: 12535795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of dual inhibitors of the immune cell PI3Ks p110delta and p110gamma: a prototype for new anti-inflammatory drugs.
    Williams O; Houseman BT; Kunkel EJ; Aizenstein B; Hoffman R; Knight ZA; Shokat KM
    Chem Biol; 2010 Feb; 17(2):123-34. PubMed ID: 20189103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3K Isoforms in Cell Signalling and Innate Immune Cell Responses.
    Galvão I; Sousa LP; Teixeira MM; Pinho V
    Curr Top Microbiol Immunol; 2022; 436():147-164. PubMed ID: 36243843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class I PI3K Biology.
    Aytenfisu TY; Campbell HM; Chakrabarti M; Amzel LM; Gabelli SB
    Curr Top Microbiol Immunol; 2022; 436():3-49. PubMed ID: 36243838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in subunits of PI3K class I in cancer.
    Cui W; Cai Y; Zhou X
    Pathology; 2014 Apr; 46(3):169-76. PubMed ID: 24614719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging mechanisms of isoform-specific PI3K signalling.
    Vanhaesebroeck B; Guillermet-Guibert J; Graupera M; Bilanges B
    Nat Rev Mol Cell Biol; 2010 May; 11(5):329-41. PubMed ID: 20379207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class II phosphatidylinositol 3-kinase isoforms in vesicular trafficking.
    Yoshioka K
    Biochem Soc Trans; 2021 Apr; 49(2):893-901. PubMed ID: 33666217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence from bioinformatics, expression and inhibition studies of phosphoinositide-3 kinase signalling in Giardia intestinalis.
    Cox SS; van der Giezen M; Tarr SJ; Crompton MR; Tovar J
    BMC Microbiol; 2006 May; 6():45. PubMed ID: 16707026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Phosphatidylinositol 3-Kinase Activity in Regulatory T Cells Leads to Neuronal Inflammation.
    Stark AK; Davenport ECM; Patton DT; Scudamore CL; Vanhaesebroeck B; Veldhoen M; Garden OA; Okkenhaug K
    J Immunol; 2020 Jul; 205(1):78-89. PubMed ID: 32414808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.